These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 17456574)

  • 61. Comparison of newborn screening protocols for congenital adrenal hyperplasia in preterm infants.
    Sarafoglou K; Gaviglio A; Hietala A; Frogner G; Banks K; McCann M; Thomas W
    J Pediatr; 2014 May; 164(5):1136-40. PubMed ID: 24582106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Reevaluation of recalled infants by neonatal mass screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Diagnostic value of pregnanetriolone in a single urine specimen using glass capillary gas chromatography].
    Hikita Y
    Nihon Naibunpi Gakkai Zasshi; 1985 Mar; 61(3):197-219. PubMed ID: 3874793
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
    Brossaud J; Barat P; Fagour L; Corcuff JB
    Clin Chim Acta; 2012 Aug; 413(15-16):1306-7. PubMed ID: 22561187
    [No Abstract]   [Full Text] [Related]  

  • 64. Scalp hair 17-hydroxyprogesterone and androstenedione as a long-term therapy monitoring tool in congenital adrenal hyperplasia.
    Noppe G; de Rijke YB; Koper JW; van Rossum EF; van den Akker EL
    Clin Endocrinol (Oxf); 2016 Oct; 85(4):522-7. PubMed ID: 27061431
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S; Dean H; Dent W; Stockl E; Cronin C
    Pediatrics; 1996 Jan; 97(1):100-2. PubMed ID: 8545200
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reversed-phase high-performance liquid chromatography separation of adrenal steroids prior to radioimmunoassay: application in congenital adrenal hyperplasia.
    Fernandes VT; Ribeiro-Neto LM; Lima SB; Vieira JG; Verreschi IT; Kater CE
    J Chromatogr Sci; 2003; 41(5):251-4. PubMed ID: 12841953
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Steroids Androstenedione, Dehydroepiandrosterone, 11-Deoxycortisol, 17-Hydroxyprogesterone, and Testosterone.
    Munar A; Clinton Frazee C; Garg U
    Methods Mol Biol; 2022; 2546():451-457. PubMed ID: 36127612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS.
    Ueland GÅ; Methlie P; Øksnes M; Thordarson HB; Sagen J; Kellmann R; Mellgren G; Ræder M; Dahlqvist P; Dahl SR; Thorsby PM; Løvås K; Husebye ES
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1696-1703. PubMed ID: 29452421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program.
    Cavarzere P; Camilot M; Teofoli F; Tatò L
    Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
    Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
    Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neonatal screening for congenital adrenal hyperplasia: transitory elevation of 17-hydroxyprogesterone.
    Huidobro Fernández B; Echeverria Fernández M; Dulin Iñiguez E; Ezquieta Zubicaray B; Roldán Martín MB; Rodríguez Arnao MD; Rodríguez Sánchez A
    J Pediatr Endocrinol Metab; 2011; 24(3-4):155-62. PubMed ID: 21648283
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling.
    Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y
    J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Determination of serum steroids in monitoring therapy of congenital adrenal hyperplasia].
    Xiao HW; Ma HM; Su Z; Du ML; Li YH; Chen HS; Chen QL
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):301-7. PubMed ID: 22801236
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS; Allen DB; Hoffman GL
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Improving neonatal screening for congenital adrenal hyperplasia.
    Speiser PW
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3685-6. PubMed ID: 15292288
    [No Abstract]   [Full Text] [Related]  

  • 77. Performance enhancement in the measurement of 5 endogenous steroids by LC-MS/MS combined with differential ion mobility spectrometry.
    Ray JA; Kushnir MM; Yost RA; Rockwood AL; Wayne Meikle A
    Clin Chim Acta; 2015 Jan; 438():330-6. PubMed ID: 25110813
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiples of Median-Transformed, Normalized Reference Ranges of Steroid Profiling Data Independent of Age, Sex, and Units.
    Zalas D; Reinehr T; Niedziela M; Borzikowsky C; Flader M; Simic-Schleicher G; Akkurt HI; Heger S; Hornig N; Holterhus PM; Kulle AE
    Horm Res Paediatr; 2018; 89(4):255-264. PubMed ID: 29694956
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Steroid 17-Hydroxyprogesterone in Hair Is a Potential Long-Term Biomarker of Androgen Control in Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
    Auer MK; Krumbholz A; Bidlingmaier M; Thieme D; Reisch N
    Neuroendocrinology; 2020; 110(11-12):938-949. PubMed ID: 31711056
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The value of low dose (1 microg) ACTH stimulation test in the investigation of non-classic adrenal hyperplasia due to 11beta-hydroxylase deficiency.
    Unlühizarci K; Keleştimur F; Güven M; Bayram F; Colak R
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):381-5. PubMed ID: 12518247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.